Azstarys is classified as a Schedule IV controlled substance in the United States [1]. This designation means it has a lower potential for abuse compared to substances in Schedules I, II, and III [2].
Why is Azstarys a Controlled Substance?
Azstarys contains a combination of dexmethylphenidate and serdexmethylphenidate. Dexmethylphenidate is a central nervous system stimulant that can be habit-forming [1]. Its inclusion in the controlled substance list is a measure to regulate its prescription and dispensing, aiming to mitigate risks associated with misuse or diversion [2].
What Does Schedule IV Classification Mean for Patients?
As a Schedule IV controlled substance, Azstarys is subject to specific regulations regarding its prescription and dispensing. This typically involves requirements for written or electronic prescriptions, with limitations on refills [2]. Healthcare providers monitor patients using these medications to ensure they are used safely and appropriately for their intended medical purpose, such as the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [1].
How is Azstarys Different from Other ADHD Medications?
Azstarys is a stimulant medication approved for the treatment of ADHD in patients six years and older [1]. It utilizes a prodrug approach, where serdexmethylphenidate is converted into dexmethylphenidate in the body, providing a sustained release of the active stimulant [1]. This mechanism aims to offer long-lasting symptom control. Other ADHD medications may include different stimulants, non-stimulants, or combinations thereof, each with varying mechanisms of action, durations of effect, and potential side effects [3].
When Does Azstarys Patent Protection End?
Information regarding the patent expiration for Azstarys would be available through specialized patent tracking resources. DrugPatentWatch.com provides comprehensive data on drug patents, including expiration dates and any associated legal challenges [4]. Without specific access to their database, precise patent expiry dates for Azstarys cannot be provided.
What Are the Side Effects of Azstarys?
Common side effects reported with Azstarys include insomnia, decreased appetite, dry mouth, nausea, and increased blood pressure [1]. Less common but serious side effects can include cardiovascular events, psychiatric issues, and the potential for abuse and dependence due to its controlled substance classification [1][2].
Who Makes Azstarys?
Azstarys is manufactured by Corium, Inc. [1].
What are the Risks of Taking Azstarys?
The risks associated with Azstarys include the potential for misuse, abuse, and dependence, as is characteristic of Schedule IV controlled substances [1][2]. Cardiovascular risks, such as an increased heart rate or blood pressure, and psychiatric effects, like new or worsening behavioral or mood symptoms, are also important considerations [1].
Can You Get Addicted to Azstarys?
Due to its classification as a Schedule IV controlled substance, Azstarys carries a risk of psychological dependence and, less commonly, physical dependence or abuse [1][2]. It is intended for use under the supervision of a healthcare professional who can monitor for signs of misuse or dependence.
Sources:
[1] https://www.azstarys.com/
[2] https://www.dea.gov/drug-scheduling
[3] https://www.additudemag.com/medications-for-adhd/
[4] https://drugpatentwatch.com/